308 related articles for article (PubMed ID: 16094219)
61. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
62. Clinical review: new technologies for prevention of intravascular catheter-related infections.
Cicalini S; Palmieri F; Petrosillo N
Crit Care; 2004 Jun; 8(3):157-62. PubMed ID: 15153233
[TBL] [Abstract][Full Text] [Related]
63. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
Crawford AG; Fuhr JP; Rao B
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
[TBL] [Abstract][Full Text] [Related]
64. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
[TBL] [Abstract][Full Text] [Related]
65. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
66. Use of a chlorhexidine-impregnated patch does not decrease the incidence of bacterial colonization of femoral nerve catheters: a randomized trial.
Schroeder KM; Jacobs RA; Guite C; Gassner K; Anderson B; Donnelly MJ
Can J Anaesth; 2012 Oct; 59(10):950-7. PubMed ID: 22855310
[TBL] [Abstract][Full Text] [Related]
67. Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.
Paglialonga F; Consolo S; Biasuzzi A; Assomou J; Gattarello E; Patricelli MG; Giannini A; Chidini G; Napolitano L; Edefonti A
Hemodial Int; 2014 Oct; 18 Suppl 1():S13-8. PubMed ID: 25330826
[TBL] [Abstract][Full Text] [Related]
68. Use of a 1-piece chlorhexidine gluconate transparent dressing on critically ill patients.
Pfaff B; Heithaus T; Emanuelsen M
Crit Care Nurse; 2012 Aug; 32(4):35-40. PubMed ID: 22855077
[TBL] [Abstract][Full Text] [Related]
69. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections.
Quach C; Milstone AM; Perpête C; Bonenfant M; Moore DL; Perreault T
Infect Control Hosp Epidemiol; 2014 Feb; 35(2):158-63. PubMed ID: 24442078
[TBL] [Abstract][Full Text] [Related]
70. Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases.
Weitz NA; Lauren CT; Weiser JA; LeBoeuf NR; Grossman ME; Biagas K; Garzon MC; Morel KD
JAMA Dermatol; 2013 Feb; 149(2):195-9. PubMed ID: 23560299
[TBL] [Abstract][Full Text] [Related]
71. Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
Buetti N; Ruckly S; Lucet JC; Mimoz O; Souweine B; Timsit JF
Intensive Care Med; 2019 Dec; 45(12):1774-1782. PubMed ID: 31624854
[TBL] [Abstract][Full Text] [Related]
72. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
Veenstra DL; Saint S; Sullivan SD
JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
[TBL] [Abstract][Full Text] [Related]
73. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial.
Garland JS; Buck RK; Maloney P; Durkin DM; Toth-Lloyd S; Duffy M; Szocik P; McAuliffe TL; Goldmann D
Pediatr Infect Dis J; 1995 Jun; 14(6):510-6. PubMed ID: 7667056
[TBL] [Abstract][Full Text] [Related]
74. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection.
Ranucci M; Isgrò G; Giomarelli PP; Pavesi M; Luzzani A; Cattabriga I; Carli M; Giomi P; Compostella A; Digito A; Mangani V; Silvestri V; Mondelli E;
Crit Care Med; 2003 Jan; 31(1):52-9. PubMed ID: 12544993
[TBL] [Abstract][Full Text] [Related]
75. Clinical experiences of using Biopatch: a chlorhexidine gluconate-impregnated sponge dressing. Case study 2: paediatric intensive care.
Franklin N
Br J Nurs; 2014; 23(14 Suppl):S21. PubMed ID: 25373254
[No Abstract] [Full Text] [Related]
76. Infectious risk associated with arterial catheters compared with central venous catheters.
Lucet JC; Bouadma L; Zahar JR; Schwebel C; Geffroy A; Pease S; Herault MC; Haouache H; Adrie C; Thuong M; Français A; Garrouste-Orgeas M; Timsit JF
Crit Care Med; 2010 Apr; 38(4):1030-5. PubMed ID: 20154601
[TBL] [Abstract][Full Text] [Related]
77. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
[TBL] [Abstract][Full Text] [Related]
78. Techniques to prevent central venous catheter infections: products, research, and recommendations.
Banton J
Nutr Clin Pract; 2006 Feb; 21(1):56-61. PubMed ID: 16439770
[TBL] [Abstract][Full Text] [Related]
79. Reducing PICU central line-associated bloodstream infections: 3-year results.
Miller MR; Niedner MF; Huskins WC; Colantuoni E; Yenokyan G; Moss M; Rice TB; Ridling D; Campbell D; Brilli RJ;
Pediatrics; 2011 Nov; 128(5):e1077-83. PubMed ID: 22025594
[TBL] [Abstract][Full Text] [Related]
80. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability.
Montecalvo MA; McKenna D; Yarrish R; Mack L; Maguire G; Haas J; DeLorenzo L; Dellarocco N; Savatteri B; Rosenthal A; Watson A; Spicehandler D; Shi Q; Visintainer P; Wormser GP
Am J Med; 2012 May; 125(5):505-11. PubMed ID: 22482848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
